Scorpius Holdings, Inc. (OTCPK: SCPX)
Health Care · Biotechnology · US
$0.00
-16.67% today · -90.0% 1Y
Scorpius Holdings, Inc. (OTCPK: SCPX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $61.14K and employs 91 people.
Over the last twelve months the share price has lost 90.0%, trading between 0.00 and 0.10.
Tweenvest scores Scorpius Holdings, Inc. across four factors: quality 6/100, value 53/100, growth 15/100. Its strongest factor is value.
SCPX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $61.14K
- Revenue (TTM)
- $1.72M
- P/E
- —
- EPS
- -0.85
- Dividend yield
- —
- Beta (5Y)
- -5.33
- 52-week high
- $0.10
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 61.14M
- Employees
- 91
- Next earnings
- —
About Scorpius Holdings, Inc.
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.
- ISIN
- US42237K5083
- Founded
- 2008
- Listed since
- Jul 24, 2013
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.